Skip to main content
Top
Published in: International Journal of Behavioral Medicine 4/2011

01-12-2011

Understanding the Functionality of Depression Among Australian Breast Cancer Patients: Implications for Cognitive and Behavioural Interventions

Authors: Christopher F. Sharpley, Vicki Bitsika, David R. H. Christie

Published in: International Journal of Behavioral Medicine | Issue 4/2011

Login to get access

Abstract

Background

Depression in breast cancer (BCa) patients can reduce quality of life, relationships and treatment compliance, thus constituting a major target for cognitive behavioural (CBT) interventions. Although CBT treatments, which are built upon consideration of the roles of antecedents and consequences for depressive behaviour, are effective, the nature of those antecedents which trigger depression among BCa patients has received relatively little attention.

Purpose

Hypotheses were (1) to determine if BCa patients were experiencing either or both of punishment type I and II and (2) to identify if these aspects of punishment were related to overall depression.

Method

Two hundred fifty-three BCa patients completed a standardised depression scale, and data were factor analysed. Components were interpreted for their relationship to punishment type I or II.

Results

Two major components emerged: (1) loss of previously available sources of personal or social reinforcement (i.e. punishment type II or negative punishment) and (2) behavioural, emotional and cognitive responses to those losses. These two components represent the total symptomatology of major depressive episode from DSM-IV-TR.

Conclusion

These findings support the application of a functional analytic model of depression within CBT assessment and treatment procedures with BCa patients.
Literature
1.
go back to reference DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62:409–16.PubMedCrossRef DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62:409–16.PubMedCrossRef
2.
go back to reference O'Neill R, Horner R, Albin R, Sprague J, Storey K, Newton J. Functional assessment and program development for problem behavior: a practical handbook. Pacific Grove: Brooks/Cole; 1997. O'Neill R, Horner R, Albin R, Sprague J, Storey K, Newton J. Functional assessment and program development for problem behavior: a practical handbook. Pacific Grove: Brooks/Cole; 1997.
3.
go back to reference Kohlenberg RJ, Tsai M. Functional analytic psychotherapy: creating intense and curative therapeutic relationships. New York: Plenum Press; 1991. Kohlenberg RJ, Tsai M. Functional analytic psychotherapy: creating intense and curative therapeutic relationships. New York: Plenum Press; 1991.
4.
go back to reference Wade T, Lee C. The impact of breast cancer on the lives of middle-aged women: results from the Australian longitudinal study of women's health. Health Psychol. 2005;24:246–51.PubMedCrossRef Wade T, Lee C. The impact of breast cancer on the lives of middle-aged women: results from the Australian longitudinal study of women's health. Health Psychol. 2005;24:246–51.PubMedCrossRef
5.
go back to reference APA. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 2000. Text Revision. APA. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 2000. Text Revision.
6.
go back to reference Love A, Grabsch B, Clarke D, Bloch S, Kissane D. Screening for depression in women with metastatic breast cancer: a comparison of the Beck depression inventory short form and the hospital anxiety and depression scale. Aust NZ J Psychiatry. 2004;38:526–31.CrossRef Love A, Grabsch B, Clarke D, Bloch S, Kissane D. Screening for depression in women with metastatic breast cancer: a comparison of the Beck depression inventory short form and the hospital anxiety and depression scale. Aust NZ J Psychiatry. 2004;38:526–31.CrossRef
7.
go back to reference Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000;356:1326–7.PubMedCrossRef Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000;356:1326–7.PubMedCrossRef
8.
go back to reference Fallowfield L. Quality of life issues in relation to the aromatase inhibitor. J Steroid Biochem Mol Biol. 2007;106:168–72.PubMedCrossRef Fallowfield L. Quality of life issues in relation to the aromatase inhibitor. J Steroid Biochem Mol Biol. 2007;106:168–72.PubMedCrossRef
9.
go back to reference Day R. Quality of life and tamoxifen in a breast cancer prevention trial. Ann NY Acad Sci. 2001;949:143–50.PubMedCrossRef Day R. Quality of life and tamoxifen in a breast cancer prevention trial. Ann NY Acad Sci. 2001;949:143–50.PubMedCrossRef
10.
go back to reference Somerset W, Stout S, Miller A, Musselman D. Breast cancer and depression. Oncology. 2004;18:1021–34.PubMed Somerset W, Stout S, Miller A, Musselman D. Breast cancer and depression. Oncology. 2004;18:1021–34.PubMed
11.
go back to reference Watson M, Haviland J, Greer S, Davidson J, Bliss J. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet. 1999;354:1331–6.PubMedCrossRef Watson M, Haviland J, Greer S, Davidson J, Bliss J. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet. 1999;354:1331–6.PubMedCrossRef
12.
go back to reference Kissane D, Grabsch B, Love A, Clarke D, Bloch S, Smith G. Psychiatric disorder in women with early stage and advanced breast cancer. Aust NZ J Psychiatry. 2004;38:320–6.CrossRef Kissane D, Grabsch B, Love A, Clarke D, Bloch S, Smith G. Psychiatric disorder in women with early stage and advanced breast cancer. Aust NZ J Psychiatry. 2004;38:320–6.CrossRef
13.
go back to reference Hersen M. Clinician's handbook of behavioral assessment. Amsterdam: Elsevier; 2006. Hersen M. Clinician's handbook of behavioral assessment. Amsterdam: Elsevier; 2006.
14.
go back to reference Sharpley C. Neurobiological pathways between chronic stress and depression. Clin Med: Psych. 2009;2:33–45. Sharpley C. Neurobiological pathways between chronic stress and depression. Clin Med: Psych. 2009;2:33–45.
15.
go back to reference Dougher MJ, Hackbert L. A behavior-analytic account of depression and a case report using acceptance-based procedures. Behav Anal. 1994;17(2):321–34. Dougher MJ, Hackbert L. A behavior-analytic account of depression and a case report using acceptance-based procedures. Behav Anal. 1994;17(2):321–34.
17.
go back to reference Kanter JW, Busch AM, Weeks CE, Landes SJ. The nature of clinical depression: symptoms, syndromes, and behavior analysis. Behav Anal. 2008;31(1):1–21. Kanter JW, Busch AM, Weeks CE, Landes SJ. The nature of clinical depression: symptoms, syndromes, and behavior analysis. Behav Anal. 2008;31(1):1–21.
18.
go back to reference Zung W. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.PubMed Zung W. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.PubMed
19.
go back to reference DeJonge J, Baneke J. The Zung self-rating depression scale: a replication study on reliability, validity and prediction. Psychol Rep. 1989;64:833–4.CrossRef DeJonge J, Baneke J. The Zung self-rating depression scale: a replication study on reliability, validity and prediction. Psychol Rep. 1989;64:833–4.CrossRef
20.
go back to reference Gabrys J, Peters K. Reliability, discriminant and predictive validity of the Zung self-rating depression scale. Psychol Rep. 1985;57:1091–6.PubMedCrossRef Gabrys J, Peters K. Reliability, discriminant and predictive validity of the Zung self-rating depression scale. Psychol Rep. 1985;57:1091–6.PubMedCrossRef
21.
go back to reference Sharpley CF, Christie DRH. ‘How I was then and how I am now’: current and retrospective self-reports of anxiety and depression in Australian women with breast cancer. Psycho-Oncol. 2007;16:752–62.CrossRef Sharpley CF, Christie DRH. ‘How I was then and how I am now’: current and retrospective self-reports of anxiety and depression in Australian women with breast cancer. Psycho-Oncol. 2007;16:752–62.CrossRef
22.
go back to reference Schaefer A, Brown J, Watson C, Plenel D, DeMotts J, Howard M, et al. Comparison of the validities of the Beck, Zung and MMPI depression scales. J Consult Clin Psychol. 1985;53:415–8.PubMedCrossRef Schaefer A, Brown J, Watson C, Plenel D, DeMotts J, Howard M, et al. Comparison of the validities of the Beck, Zung and MMPI depression scales. J Consult Clin Psychol. 1985;53:415–8.PubMedCrossRef
23.
go back to reference Zung W. From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry. 1973;29:328–37.PubMed Zung W. From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry. 1973;29:328–37.PubMed
24.
go back to reference Tabachnick B, Fidell L. Using multivariate statistics. 4th ed. Boston: Allyn & Bacon; 2001. Tabachnick B, Fidell L. Using multivariate statistics. 4th ed. Boston: Allyn & Bacon; 2001.
Metadata
Title
Understanding the Functionality of Depression Among Australian Breast Cancer Patients: Implications for Cognitive and Behavioural Interventions
Authors
Christopher F. Sharpley
Vicki Bitsika
David R. H. Christie
Publication date
01-12-2011
Publisher
Springer US
Published in
International Journal of Behavioral Medicine / Issue 4/2011
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-010-9098-5

Other articles of this Issue 4/2011

International Journal of Behavioral Medicine 4/2011 Go to the issue